###begin article-title 0
Short Telomeres Initiate Telomere Recombination in Primary and Tumor Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: TAM CWG. Performed the experiments: TAM. Analyzed the data: TAM. Contributed reagents/materials/analysis tools: TAM. Wrote the paper: TAM CWG.
###end p 1
###begin p 2
###xml 853 860 852 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 865 873 864 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 237 242 <span type="species:ncbi:4932">yeast</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
###xml 909 914 <span type="species:ncbi:9606">human</span>
###xml 1321 1326 <span type="species:ncbi:10090">mouse</span>
###xml 1338 1343 <span type="species:ncbi:9606">human</span>
Human tumors that lack telomerase maintain telomeres by alternative lengthening mechanisms. Tumors can also form in telomerase-deficient mice; however, the genetic mechanism responsible for tumor growth without telomerase is unknown. In yeast, several different recombination pathways maintain telomeres in the absence of telomerase-some result in telomere maintenance with minimal effects on telomere length. To examine non-telomerase mechanisms for telomere maintenance in mammalian cells, we used primary cells and lymphomas from telomerase-deficient mice (mTR-/- and Emumyc+mTR-/-) and CAST/EiJ mouse embryonic fibroblast cells. These cells were analyzed using pq-ratio analysis, telomere length distribution outliers, CO-FISH, Q-FISH, and multicolor FISH to detect subtelomeric recombination. Telomere length was maintained during long-term growth in vivo and in vitro. Long telomeres, characteristic of human ALT cells, were not observed in either late passage or mTR-/- tumor cells; instead, we observed only minimal changes in telomere length. Telomere length variation and subtelomeric recombination were frequent in cells with short telomeres, indicating that length maintenance is due to telomeric recombination. We also detected telomere length changes in primary mTR-/- cells that had short telomeres. Using mouse mTR+/- and human hTERT+/- primary cells with short telomeres, we found frequent length changes indicative of recombination. We conclude that telomere maintenance by non-telomerase mechanisms, including recombination, occurs in primary cells and is initiated by short telomeres, even in the presence of telomerase. Most intriguing, our data indicate that some non-telomerase telomere maintenance mechanisms occur without a significant increase in telomere length.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 283 288 <span type="species:ncbi:4932">yeast</span>
###xml 485 490 <span type="species:ncbi:10090">mouse</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
###xml 1347 1352 <span type="species:ncbi:9606">human</span>
Telomeres shorten with each cell division and are normally maintained by telomerase. Tumor cells typically up-regulate telomerase to maintain telomeres during rapid growth; however, some tumors lack telomerase and utilize alternative mechanisms to maintain the telomeres. Studies in yeast indicate that recombination contributes to telomere maintenance in the absence of telomerase. To examine whether recombination contributes to non-telomerase mechanisms for telomere maintenance in mouse and human cells, we utilized mouse primary and tumor cells, which were genetically deleted for telomerase. In addition, we assayed human primary cells that had short telomeres due to reduced telomerase activity. Our data indicate that cells with short telomeres have an increased level of telomere recombination, which can occur in telomeric or subtelomeric regions. We also found that, in addition to tumor cells, primary cells can utilize non-telomerase mechanisms for telomere maintenance. Lastly, we found that, unlike human telomerase negative tumors, some mechanisms of telomere maintenance do not result in dramatic telomere lengthening. Thus, mammalian cells likely utilize several different non-telomerase mechanisms for telomere maintenance. These findings will be useful for understanding the process of telomere lengthening in various types of human tumors.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Greider1">[1]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Wright1">[2]</xref>
###xml 230 233 230 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Allsopp1">[3]</xref>
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Bryan1">[4]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Kim1">[5]</xref>
###xml 606 609 606 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Blasco1">[6]</xref>
###xml 610 613 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser1">[7]</xref>
###xml 113 119 <span type="species:ncbi:9606">humans</span>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
Telomere length is maintained by the ribonucleoprotein complex telomerase [1]. However, telomerase expression in humans occurs primarily in early development, germ cells, and in stem cells and is not detected in primary cells [2],[3]. Most human tumor cells have detectable telomerase activity, however some proliferating tumors lack telomerase and thus maintain telomeres by alternative mechanisms that are collectively termed ALT for alternative lengthening of telomeres [4],[5]. While mTR-/- mice have a reduced frequency and rate of tumor formation, some tumors form and can grow rapidly in these mice [6],[7]. However, the mechanism by which tumors grow in the absence of telomerase is not known.
###end p 6
###begin p 7
###xml 116 119 116 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Blasco1">[6]</xref>
###xml 281 284 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Blasco1">[6]</xref>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Kipling1">[8]</xref>
###xml 775 778 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hemann1">[9]</xref>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hao1">[10]</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hao1">[10]</xref>
###xml 1219 1223 1219 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hao1">[10]</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 267 272 <span type="species:ncbi:10090">mouse</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
###xml 768 774 <span type="species:ncbi:9606">humans</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
###xml 1317 1321 <span type="species:ncbi:10090">mice</span>
Telomerase deficient mice were initially generated by deleting the gene encoding the telomerase RNA (mTR) component [6]. Although mTR-/- mice lack telomerase activity, no phenotype is observed in the first generation, due to the long telomeres observed in laboratory mouse strains [6],[8]. When mTR-/- mice are bred, progressive telomere shortening occurs in successive generations. Early generation, mTR-/-G1, mice are obtained by crossing mTR+/- mice. Crossing the knockouts through successive generations results in mTR-/- G2-G6 generations. Late generation mTR-/- G4-G6 mice have short telomeres and show loss of fertility due to germ cell apoptosis. Wild-derived mouse strains such as CAST/EiJ have significantly shorter telomere length distributions, similar to humans [9]. CAST/EiJ mTR+/- mice bred for increasing generations show progressive telomere shortening and loss of tissue renewal capacity [10]. The phenotypes in the mTR+/- CAST/EiJ mice mimic the human genetic disease, dyskeratosis congenita, due to haploinsuffiency for telomerase [10]. Wildtype mice derived from an intercross between late generation heterozygous parents (termed WT*) have shorter telomeres and also display tissue renewal defects [10]. Thus, telomere shortening and consequent loss of tissue renewal capacity occurs in CAST/EiJ mice even in the presence of telomerase, and provides the opportunity to examine the effects of short telomeres in the presence of telomerase.
###end p 7
###begin p 8
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Bryan2">[11]</xref>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Bryan1">[4]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Bryan2">[11]</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Murnane1">[13]</xref>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Dunham1">[14]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Yeager1">[15]</xref>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Cesare1">[16]</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Bailey1">[17]</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-LondonoVallejo1">[18]</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
###xml 1022 1027 <span type="species:ncbi:9606">human</span>
Several lines of evidence indicate that ALT occurs by DNA recombination in human tumors and immortalized cells [11]. First, the initial description of ALT demonstrated that the telomeres are exceptionally long and heterogeneous in human tumors and immortalized cell lines which lack telomerase [4]. Second, telomere lengths in ALT cells fluctuate during proliferation, and this fluctuation can be detected by examining the change in the telomere lengths at the p- and q-arm of the Y-chromosome in a rapidly growing culture [11]-[13]. Third, a unique plasmid sequence integrated as single copy at the telomere was found duplicated at other chromosomes following serial transfer of human ALT cells [14]. ALT associated nuclear promyelocytic leukemia bodies (APBs) are found in a subset of human ALT cell lines and contain various recombination proteins [15]. However it is uncertain what functional role APBs contribute to ALT mechanisms and they are often considered as only a marker for some ALT cell lines [16]. Finally, human ALT tumors show frequent telomere sister chromatid exchanges (T-SCEs), that are detectable using chromosome orientation FISH (CO-FISH) [17],[18].
###end p 8
###begin p 9
###xml 99 123 99 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Lundblad1">[19]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Lundblad1">[19]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Teng1">[20]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Chen1">[21]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Le1">[22]</xref>
###xml 1017 1021 1017 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Le1">[22]</xref>
###xml 1022 1026 1022 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-McEachern1">[23]</xref>
###xml 1123 1127 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Le1">[22]</xref>
###xml 1128 1132 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-McEachern1">[23]</xref>
###xml 1145 1165 1145 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kluyveromyces lactis</italic>
###xml 1246 1254 1246 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K.lactis</italic>
###xml 1279 1283 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ter1</italic>
###xml 1352 1356 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-McEachern2">[24]</xref>
###xml 99 123 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 125 130 <span type="species:ncbi:4932">Yeast</span>
###xml 331 336 <span type="species:ncbi:4932">yeast</span>
###xml 1042 1047 <span type="species:ncbi:4932">yeast</span>
###xml 1145 1165 <span type="species:ncbi:28985">Kluyveromyces lactis</span>
###xml 1246 1254 <span type="species:ncbi:28985">K.lactis</span>
###xml 1361 1366 <span type="species:ncbi:10090">mouse</span>
###xml 1371 1376 <span type="species:ncbi:9606">human</span>
###xml 1697 1702 <span type="species:ncbi:10090">mouse</span>
Evidence that recombination contributes to telomere length maintenance was initially discovered in Saccharomyces cerevisiae. Yeast lacking an essential component of telomerase showed progressive telomere shortening and loss of viability, however survivors appeared after successive streaking of the colonies [19]. Studies of these yeast survivors showed that telomere recombination contributes to length maintenance, and requires the RAD52 pathway [19]. Survivors can be classified as Type I or Type II based on their telomere patterns and growth rate [20],[21]. Type I survivors require Rad51, Rad54, Rad55 and Rad57 [22]. The telomeres of Type I survivors are short and the cells have amplified Y' sequence. They are likely generated by Rad51-dependent break-induced replication (BIR). Type II survivors grow much more rapidly than Type I survivors. They have elongated telomere sequence tracts, require Rad59, Rad50 and other components of the MRX complex, and are predominately generated by Rad51-independent BIR [22],[23]. Therefore, in yeast, telomere elongation in the absence of telomerase occurs mostly though BIR [22],[23]. Studies in Kluyveromyces lactis have also provided insight on telomere recombination mechanisms. In particular, K.lactis deleted for telomerase (ter1) showed that telomere recombination is initiated by short telomeres [24]. In mouse and human cells the T-SCE assay, which is frequently used to measure telomere recombination, will not detect recombination by BIR mechanisms. Further, T-SCEs are exchanges and thus will not result in net telomere elongation as occurs in BIR. Thus we sought to use other assays to examine telomere recombination in telomerase null mouse cells.
###end p 9
###begin p 10
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
To examine the role of short telomeres during telomere recombination in mammalian cells we assayed cells using pq-ratios, outliers, CO-FISH, and Q-FISH from two different strains of telomerase deficient (mTR-/-) mice. We found that late passage CAST/EiJ mouse embryonic fibroblasts (MEFs) and Emumyc+mTR-/- lymphomas with short telomeres, exhibit telomere maintenance with minimal changes to the overall length distribution. Consistent with telomere recombination, we observed an increase in pq-ratio changes and outliers in mouse cells with increasing numbers of short telomeres. We directly showed that subtelomeric recombination is increased in cells with elevated pq-ratio changes. These pq-ratio changes were seen associated with short telomeres even in telomerase positive cells, suggesting that telomerase itself does not protect against recombination. Our data suggest that, several distinct recombination-based mechanisms can contribute to telomere maintenance in mammalian cells.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 12
###begin p 13
###xml 64 67 64 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Blasco1">[6]</xref>
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hao1">[10]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hemann2">[25]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser2">[26]</xref>
###xml 255 258 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser1">[7]</xref>
###xml 412 413 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 439 440 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 74 78 <span type="species:ncbi:10090">Mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">Mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
C57BL/6J mTR-/- and CAST/EiJ mTR-/- were generated as described [6],[10]. Mice used for the intergenerational cross were generated as previously described [25],[26]. EmuMyc+mTR-/- mice were bred and B-cell lymphomas were collected as previously described [7]. Mice were genotyped by Transnetyx (Cordova, TN). For serial transfers of tumors, B-cell lymphomas were isolated from mice and resuspended in PBS at 1x107 cells/ml. A total of 1x106 cells (0.1 ml) were subcutaneously injected into three SCID mice, two sites each (Taconic). All animals were housed and bred in a pathogen-free environment and procedures approved by the Institutional Animal Care and Use Committee at The Johns Hopkins University.
###end p 13
###begin title 14
Primary and Tumor Cell Culture and Metaphase Preparation
###end title 14
###begin p 15
###xml 1660 1664 1620 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Armanios1">[27]</xref>
###xml 808 814 <span type="species:ncbi:9913">bovine</span>
###xml 1256 1260 <span type="species:ncbi:10090">mice</span>
###xml 1574 1580 <span type="species:ncbi:9913">bovine</span>
###xml 1604 1609 <span type="species:ncbi:9606">human</span>
###xml 1666 1671 <span type="species:ncbi:10090">Mouse</span>
Splenocytes and bone marrow, from the tibias and femurs, were harvested from 8-10 week old animals. Bone marrow was collected by flushing the bones with 1x PBS, pH 7.4 (GIBCO) with a 23-gauge needle. Cells were resuspended in MarrowMax media (GIBCO), and immediately incubated with 0.1 microg/ml of KaryoMax Colcemid solution (GIBCO) for 20 minutes, and harvested for metaphase spread analysis. Cells were swelled in 75 mM KCl hypotonic solution at 37degreesC for 15 minutes, and fixed with (3:1) methanol: acetic acid with three repeated exchanges prior to dropping onto slides. Splenocyte suspensions were generated using 70 microm Nylon cell strainers (BD Falcon), and were activated in RPMI 1640 with L-glutamine (GIBCO) supplemented with 1x penicillin-streptomycin-glutamine, 10% heat inactivated fetal bovine serum, 10 mM HEPES buffer, 1 mM sodium pyruvate (GIBCO), 1x non-essential amino acids (GIBCO), 50 microM ss-mercaptoethanol (Sigma), 10 microg/ml LPS (Sigma), 1 U/ml IL-2 (Roche), and 5 microg/ml ConA (Sigma). Splenocytes were cultured for 48 hours prior to the addition of 0.1 microg/ml of KaryoMax colcemid solution. Cells were incubated in colcemid for 20 minutes and metaphases prepared as described above. Lymphomas were collected from mice and single cell suspensions were generated using a 70 microm nylon cell strainer (BD Falcon). Cells were grown in a (1:1) mixture of DMEM and Iscove's modified Eagle's media supplemented with 4 mM L-glutamine, 100 Units/ml of penicillin-streptomycin, 100 microM ss-mercaptoethanol, and 10% heat inactivated fetal bovine serum. Metaphases from human lymphocytes were acquired as previously described [27]. Mouse embryonic fibroblasts were harvested in 1x PBS containing 1x penicillin, streptomycin, and fungizone (PSF, Invitrogen) at embryonic day 13.5. Cells were incubated in 0.25% trypsin-EDTA for 20 minutes at 4degreesC, and further digested at 37degreesC for 5 minutes. Cells were transferred to DMEM containing 10% FCS and PSF. 24 hours post plating attached cells were washed in 1x PBS and new DMEM was added and split approximately24-48 hours later when cells were approximately80% confluent.
###end p 15
###begin title 16
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Situ</italic>
Fluorescent In Situ Hybridization Including Quantitative (Q-FISH), CO-FISH, and Multicolor FISH
###end title 16
###begin p 17
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser2">[26]</xref>
###xml 1556 1557 1504 1505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1566 1567 1514 1515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1570 1571 1518 1519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1610 1614 1558 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Laud1">[28]</xref>
###xml 1890 1895 <span type="species:ncbi:10090">mouse</span>
###xml 2081 2086 <span type="species:ncbi:10090">mouse</span>
Metaphase spreads were processed for Q-FISH as previously described [26]. For CO-FISH, the cells were incubated for 24 hours in 30 microM of 5'-bromo-2'deoxyuridine (BrdU, Sigma) and 10 microM 5'bromo-2'deoxycytidine (BrdC, Berry & Associates). Bone marrow was incubated for 20 minutes and splenocytes for 2 hours in 0.2 microg/ml of colcemid and harvested for metaphases as described above. Metaphase spreads were rehydrated in 1x PBS pH 7.4 for 15 minutes and fixed in 4% formaldehyde in 1x PBS pH 7.4 for 2 minutes. All washes were done between treatments with 1x PBS and dehydrated in an ethanol series of 70%, 90% and absolute ethanol. Slides were treated with 1 mg/ml of pepsin at 37degreesC for 10 minutes, fixed in 4% formaldehyde in 1x PBS pH 7.4, dehydrated and treated with 500 microg/ml of RNase A in 2x SSC for 10 minutes at 37degreesC, and stained with 0.5 microg/ml of Hoechst 33258 (Sigma) for 15 minutes at room temperature, air-dried, and 100 microl of 2x SSC was added with a cover slip prior to a 30 minute UV exposure at 365 nm in an 1800 Stratalinker (Stratagene). Slides were digested with 3 U/microl of Exo III in 1x buffer (Promega) for 10 minutes at 37degreesC. Slides were hybridized with a telomere probe as described above for Q-FISH. Antibody staining to BrdU was used in order to avoid metaphases that underwent two rounds of replication. For BrdU staining, slides were washed in 2x SSC and incubated for 30 minutes at 37degreesC in a 1:100 dilution of FITC anti-BrdU (Molecular Probes, Invitrogen) in PN buffer (0.1 M NaH2PO4/0.1 M Na2HPO4 pH 8.0, 1% Triton X-100) as described [28]. The slides were rinsed two times for 5 minutes each in PN buffer, prior to mounting with Vectashield. For multicolor FISH the subtelomeric clone (JHU1193) was acquired from Invitrogen (RPCI-23 391E5) and purified using HiPure Plasmid Filter Purification kit (Invitrogen). A mouse chromosome 2 specific paint probe was acquired from Applied Spectral Imaging (ASI). BAC DNA (1.5 ug) was labeled by Biotin-Nick Translation (Roche), ethanol precipitated with 15 microg mouse Cot-1 DNA (Invitrogen), and 1.5 microg of fish sperm DNA (Roche), and resuspended in 10 microl of formamide using a thermomixer at 37degreesC. 20 microl of probe hybridization buffer (20% Dextran sulfate, 2xSSC) was added, and the probe was denatured at 80degreesC for 5 minutes and pre-annealed at 37degreesC for one hour. Slides were pretreated as described for Q-FISH, denatured at 80degreesC in 70% formamide/2x SSC, and dehydrated in an ethanol series, prior to hybridization for 48 hour at 37degreesC. Slides are washed at 45degreesC in 50% formamide, 2x SSC for 3x 5 minutes and at 60degreesC in 0.1x SSC for 3x 5 minutes. Slides were dipped in 4x SSC/0.1% Tween 20 and 50 microl of denatured and pre-annealed chromosome 2 paint probe was hybridized for 48 hours at 37degreesC. Slides were washed in 0.4x SSC at 72degreesC for 3x 5 minutes and washed 2x 2 minutes each in 4x SSC/0.1% Tween 20. For detection of the BAC hybridization, slides were blocked in (3% BSA/4x SSC/0.1% Tween 20) for 30 minutes at 37degreesC for 30 minutes. Slides were washed for 2 minutes in 4x SSC/0.1% Tween 20 and streptavidin Alexa Fluor 488 (Molecular Probes, Invitrogen) conjugated antibody was diluted 1:100 and incubated at 37degreesC for 45 minutes. Slides were washed in 4x SSC/0.1% Tween 20 at 45degreesC, 3x 5 minutes and dehydrated in an ethanol series. Slides were stained and visualized as described for Q-FISH.
###end p 17
###begin title 18
Pq-Ratios, Outliers, and Statistical Analysis
###end title 18
###begin p 19
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Zijlmans1">[29]</xref>
###xml 868 872 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Pagano1">[30]</xref>
Telomere ratios were determined by initially measuring by Q-FISH the telomere lengths with TFL-Telo (Version 2.0) [29]. For each chromosome, the telomere signals were scored for location (p or q), and the final value of q/p was determined for each chromosome of multiple metaphases. 5-fold ratio values (q/p>/=5 or q/p</=0.2) were plotted and normalized for the total number of chromosomes examined for each genotype. T-tests were used to determine statistical significance. Chromosomes with a single signal-free end were considered to have a q/p greater than 5-fold. The number of outliers was calculated by generating box plots using Stata 8.0. The box plots were generated using the Q-FISH values from the same metaphases examined for telomere ratio analysis. The test for statistical significance of outliers was done using the Wilcoxon rank sum test as described [30].
###end p 19
###begin title 20
Southern Analysis
###end title 20
###begin p 21
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 771 772 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1088 1104 1066 1082 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTAGGG/CCCTAA</named-content>
###xml 1263 1265 1229 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1308 1310 1266 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1441 1442 1399 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1475 1476 1433 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Bone marrow and splenocytes were resuspended in 1% PBSa agarose at a final concentration of 1x107 cells/ml, incubated in LDS (1% lithium dodecyl sulfate/100 mM EDTA pH 8.0, 10 mM Tris pH 8.) at 37degreesC O/N with constant agitation, and washed twice in 20% NDS for 2 hours at 37degreesC with constant agitation. Prior to digestion, plugs were washed twice in TE for 30 minutes and then washed twice in 400 microl of 1x Buffer #2 (NEB) for 30 minutes prior to MseI restriction digestion. Plugs were digested overnight and loaded on a 0.7% TAE agarose gel. Samples were run at 100V for 6-8 hours. Following denaturation (0.5 M NaOH/1.5 M NaCl) and neutralization (1.5 M NaCl/0.5 M Tris-HCL pH 7.4), the DNA was transferred in 20x SSC to a Nylon Membrane (Amersham Hybond N+) by weighting method overnight and cross-linked with UV Stratalinker (Stratagene). Pre-hybridization was done at 65degreesC in Church's buffer for 2 hours. A radioactive telomere probe was made by random-prime labeling using Prime-It II (Stratagene) with a slight modification. Briefly, 25 ng of a 500 bp telomeric 5'-TTAGGG/CCCTAA containing probe, acquired from EcoR1 digestion of JHU821 or 1 KB Plus DNA ladder (Invitrogen) was labeled using 33 microM of dATP, dTTP, 50 microCi of alpha-32P dCTP (3000 Ci/mmol) and 50 microCi alpha-32P dGTP (3000 Ci/mmol). Unincorporated nucleotides were removed using a G50 column (GE Healthcare). Labeled probe was counted and 106 counts/ml (telomere probe) or 105 counts/ml (ladder) was denatured at 100degreesC for 5 minutes and added to the pre-hybridization solution and hybridized overnight at 65degreesC. Membranes were washed 3x 15 minutes each in 6x SSC and 1%SDS at 65degreesC, and 3x 15 minutes each in 1x SSC and 1% SDS at 65degreesC and exposed to a phosphorimager screen and detected on a Fuji phosphorimager.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
Telomere Lengths Are Maintained with Minimal Changes to the Overall Length Distribution
###end title 23
###begin p 24
###xml 202 205 202 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hemann1">[9]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Todaro1">[31]</xref>
###xml 320 329 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g001">Figure 1A</xref>
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Blasco1">[6]</xref>
###xml 534 589 534 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g001">Figure 1 D&#8211;F, compare p3 to p29 and p45, data not shown</xref>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 834 839 <span type="species:ncbi:4932">yeast</span>
To examine the contribution of non-telomerase mechanisms to telomere maintenance, we serially passaged CAST/EiJ mTR-/- mouse embryonic fibroblasts (MEFs), which have short, homogeneous telomere lengths [9],[31]. After extensive passage, MEF cultures were immortalized as seen for mTR-/- MEFs on the C57BL/6J background (Figure 1A) [6]. Despite extensive passage of these MEFs, Q-FISH and Southern analysis indicated minimal changes to the telomere lengths in both mTR+/- and mTR-/- cell lines when compared to early passage cultures (Figure 1 D-F, compare p3 to p29 and p45, data not shown). These findings indicate that despite immortalization, MEFs lacking telomerase do not undergo extensive telomere lengthening. We reasoned that non-telomerase mechanisms for telomere maintenance may be occurring, similar to Type I survivors in yeast, which result in telomere maintenance without extensive lengthening.
###end p 24
###begin title 25
Telomere maintenance occurs in mTR-/- cells.
###end title 25
###begin p 26
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Todaro1">[31]</xref>
###xml 532 536 532 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 615 616 615 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 779 780 779 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 801 802 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 909 913 909 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 925 926 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 934 935 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 947 948 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
A. Growth curves for CAST/EiJ MEFs derived from littermates from an HG1xHG1 cross. Cells were passaged according to previous reports [31]. Cell growth increased after a brief period of senescence and cells were considered immortalized after passage 16. B. Q-FISH on myc+mTR+/+ lymphomas serially passaged in SCID mice. C. Q-FISH on myc+mTR-/-G5 lymphomas serially passaged in SCID mice. D-F. Shown are the Q-FISH analysis of MEFs at passage 3 (p3), passage 29 (p29), and passage 45 (p45). The telomere lengths of both the HG2 and KO(G2) were not dramatically lengthened. D. The WT2* mean telomere lengths are 3.1x105, 3.5x105, and 1.6x105, the amount of signal free ends (SFEs) were, 1, 4, and 9, for p3, p29 and p45 respectively. E. For HG2 the mean telomere lengths were 2.6x105, 2.0x105, and 1.8x105 and the SFEs were, 2, 23, and 19 for p3, p29 and p45 respectively. F. The mean telomere lengths for the KO(G2) were 2.6x105, 1.5x105, and 1.3x105, and the amount of SFEs were 16, 44, and 156 for P3, p29 and p45 respectively.
###end p 26
###begin p 27
###xml 211 215 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Adams1">[32]</xref>
###xml 454 457 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser1">[7]</xref>
###xml 542 552 538 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s001">Figure S1A</xref>
###xml 716 732 709 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s001">Figure S1B and C</xref>
###xml 1176 1188 1164 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s001">Figure S1A&#8211;C</xref>
###xml 1382 1398 1369 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g001">Figure 1 B and C</xref>
###xml 118 133 <span type="species:ncbi:10090">transgenic mice</span>
###xml 198 201 <span type="species:ncbi:8790">Emu</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
###xml 1577 1582 <span type="species:ncbi:10090">mouse</span>
We next asked whether such maintenance also occurs in transformed tumor cells lacking telomerase. We utilized Emumyc+ transgenic mice that harbor the c-myc oncogene expressed by the B-cell specific Emu promoter [32]. These mice invariably develop B-cell lymphoma and die from the tumor by six months of age. We generated Emumyc+ mice with short telomeres. The tumor progression was dramatically reduced in the Emumyc+ mTR-/- G6 mice with short telomeres [7]. However some tumors did form in these mice, and allowed for analysis using Q-FISH (Figure S1A). We first examined the telomere lengths in primary bone marrow and splenocytes from Emumyc+mTR+/+, Emumyc+mTR-/- G1, and Emumyc+mTR-/- G4 and G6 tumor-free mice (Figure S1B and C). In primary cells, the telomere lengths were shorter in the late Emumyc+mTR-/- generations compared to the early generations and when compared to Emumyc+mTR+/+ cells. We next examined telomere lengths of the tumors that formed in Emumyc+mTR+/+, Emumyc+mTR-/- G1, and Emumyc+mTR-/- G4 and G6 mice. We found that the telomerase negative tumors did not exhibit exceptionally longer telomeres when compared to primary bone marrow or splenocytes (Figure S1A-C). To examine if the telomeres could be maintained in the absence of telomerase, tumors with short telomeres (Emumyc+mTR-/-G5) were serially passaged by transplantation into new recipient mice (Figure 1 B and C). Telomere lengths were examined, and again we observed minimal changes in telomere length in primary versus secondary lymphomas. Thus we conclude that both immortalized primary mouse cells and tumor cells can maintain telomere lengths in the absence of telomerase using non-telomerase mechanisms for telomere maintenance.
###end p 27
###begin title 28
Pq-Ratio Changes Are Increased in Primary and Tumor Cells with Short Telomeres
###end title 28
###begin p 29
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Perrem1">[12]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Zijlmans1">[29]</xref>
###xml 1254 1264 1254 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s002">Figure S2A</xref>
###xml 1334 1344 1334 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s002">Figure S2B</xref>
###xml 1478 1482 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Perrem1">[12]</xref>
###xml 1484 1494 1484 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s002">Figure S2C</xref>
###xml 1746 1754 1746 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2</xref>
###xml 1759 1768 1759 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s003">Figure S3</xref>
###xml 1959 1976 1959 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s001">Figure S1 D and E</xref>
###xml 2222 2233 2222 2233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2A&#8211;F</xref>
###xml 2372 2381 2372 2381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2G</xref>
###xml 2456 2475 2456 2475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2A, B, and G</xref>
###xml 2588 2606 2588 2606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2C, D and G</xref>
###xml 2743 2761 2743 2761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2E, F and G</xref>
###xml 2954 2963 2954 2963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2G</xref>
###xml 1201 1206 <span type="species:ncbi:10090">mouse</span>
###xml 1358 1363 <span type="species:ncbi:9606">human</span>
###xml 1397 1402 <span type="species:ncbi:10090">mouse</span>
###xml 1821 1825 <span type="species:ncbi:10090">mice</span>
###xml 1863 1867 <span type="species:ncbi:10090">mice</span>
###xml 2004 2008 <span type="species:ncbi:10090">mice</span>
###xml 2086 2090 <span type="species:ncbi:10090">mice</span>
Since we observed that telomerase negative tumors and CAST/EiJ MEFs appear to be utilizing non-telomerase mechanisms to maintain telomeres, we sought to determine the basis of this telomere maintenance mechanism that occurred without significant changes to telomere lengths. We examined whether short telomeres may initiate the non-telomerase maintenance mechanisms operating in these cells. We utilized a previously described pq-ratio assay, which can account for different types of telomere recombination mechanisms [12]. This assay is based on the Q-FISH assay, which quantitates the telomere length on metaphase spreads [29]. As cells divide in culture, both telomeres of a given chromosome should shorten by similar amounts. This results in a near constant telomere ratio at the p and q arms for each individual chromosome in a population of growing cells. However, if recombination occurs, it will alter the length of at least one telomere by a random amount. Thus the ratio of the telomere signal on the two ends of a chromosome that underwent recombination will differ from the other copies of that chromosome in the population. For pq-ratio analysis, we initially calculated the pq-ratio for mouse chromosome 1 in a population of growing cells (Figure S2A). Cells expressing telomerase had few changes in the telomere ratio (Figure S2B). Similar to human ALT cell lines, we observed that mouse tumor cells lacking telomerase were increased for changes in the pq-ratios [12] (Figure S2C). Given that this analysis of a single chromosome could be expanded to examine the changes within the entire set of chromosomes of a given metaphase, we proceeded by examining the pq-ratio of every chromosome in a minimum of ten different metaphases (Figure 2 and Figure S3). We first examined primary bone marrow from mTR+/+ mice and early and late generation mTR-/- mice (mTR-/-G1 and mTR-/-G4). Metaphase spreads were examined for telomere length using Q-FISH (Figure S1 D and E). Late generation mTR-/-G4 mice had significantly shorter telomeres than mTR+/+ or early generation mTR-/-G1 mice. We next examined the pq-ratios from metaphase spreads from a population of growing cells and plotted the ratio for each genotype (Figure 2A-F). To quantitate the changes in the pq-ratios, we focused on the percent of chromosomes that had a pq-ratio change of greater than 5-fold (Figure 2G). In mTR+/+ bone marrow the pq-ratios seldom changed from a value near 1 (Figure 2A, B, and G). Compared to mTR+/+, mTR-/-G1 primary bone marrow cells were significantly increased for changes in pq-ratios (Figure 2C, D and G). mTR-/- G4 cells with even shorter telomeres also showed a significant increase in the number of altered pq-ratios compared to mTR+/+ (Figure 2E, F and G). These changes in pq-ratios occurred in all metaphases examined, and were not specific to individual metaphases. Similar findings were also observed with splenocytes from the same genotypes (Figure 2G). The greater amount of changes in the pq-ratios in cells with shorter telomeres likely reflects non-gradual additions or deletions of telomere sequence that occurs during recombination.
###end p 29
###begin title 30
Pq-ratio changes are increased in early and late generation in mTR-/- cells with short telomeres.
###end title 30
###begin p 31
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 209 215 209 215 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCCTAA</named-content>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1401 1403 1391 1393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1432 1434 1422 1424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1527 1530 1517 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;26</sup>
###xml 1559 1562 1549 1552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 2013 2015 1999 2001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 2044 2046 2030 2032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 2168 2171 2154 2157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 2200 2203 2186 2189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Telomere fluorescence in situ hybridization on metaphase spreads from primary bone marrow cells isolated from C57BL/6J mice, (A) mTR+/+, (C) mTR-/-G1 and (E) mTR-/-G4. Telomeres were hybridized with a Cy3-5' (CCCTAA)3 telomere probe (red) and chromosomes are stained with DAPI (blue). Cy3-fluorescent intensity correlates with telomere length. B, D, F. The ratios (q/p) of the p and q telomere signals for each chromosome are plotted. 8-15 metaphases were examined for each genotype. Ratios (q/p) were calculated based on the telomere fluorescent intensity of the p- and q-arms of a given chromosome. The individual chromosomes assayed for each genotype are shown on the x-axis and the q/p ratio on the y-axis. The y-axis is on a log scale plot and excludes SFEs, since these values cannot be plotted on log scale. Changes in pq-ratios occurred for all metaphases, and were not specific to an individual metaphase, which is appreciated given that the chromosomes from each metaphase are graphed from left to right. G. The bar graph shows the percent of the total number of chromosomes with telomere ratio values of q/p>/=5-fold (q/p>/=5 or q/p</=0.2). Error bars represent the standard error of the mean. Values are shown for both primary bone marrow and splenocytes. Student T-tests, assuming alpha = .05, show statistical significance and were used to compare WT and mTR-/-G1 bone marrow (P = 3.8x10-6) and splenocytes (P = 8.3x10-7). Statistical significance was also observed between WT and mTR-/-G4 bone marrow (P = 3.6x10-26) and splenocytes (P = 8.8x10-18). Circles represent the mean telomere lengths plotted on the right y-axis. H. Pq-ratio changes determined for primary (pre-tumor) bone marrow and splenocytes as well as B-cell lymphomas plotted on the left y-axis. Error bars represent SEM. The circles represent the mean telomere length plotted on the right y-axis. Statistical significance was observed using a T-test (alpha = .05) between myc+mTR+/+ and myc+mTR-/-G1 primary bone marrow (P = 2.3x10-8) and splenocytes (P = 6.6x10-7). Similarly, statistical significance was observed between myc+mTR+/+ and myc+mTR-/-G4/G6 primary bone marrow (P = 1.4x10-18) and splenocytes (P = 3.3x10-15).
###end p 31
###begin p 32
###xml 244 253 241 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2H</xref>
###xml 383 392 378 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2H</xref>
###xml 440 449 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2H</xref>
We next asked whether Emumyc+mTR-/- primary cells with short telomeres were also increased for changes in the pq-ratios. Comparisons between Emumyc+mTR-/-G1 and Emumyc+mTR+/+ primary bone marrow showed a 11-fold increase in variable pq-ratios (Figure 2H). We also observed a 40-fold increase in pq-ratio changes between Emumyc+mTR-/- G4 and G6 compared to Emumyc+mTR+/+ bone marrow (Figure 2H). Similar trends were observed in splenocytes (Figure 2H). Thus similar to mTR-/- primary cells with short telomeres, Emumyc+ mTR-/- primary cells with short telomeres were increased for changes in the pq-ratios.
###end p 32
###begin p 33
###xml 118 127 117 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2H</xref>
###xml 132 141 131 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s003">Figure S3</xref>
###xml 754 763 747 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figure 2H</xref>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
To determine whether similar changes in pq-ratios occurred in telomerase negative tumors, we examined Emumyc+ tumors (Figure 2H and Figure S3). Emumyc+mTR-/-G1 tumors showed a 37-fold increase in pq-ratios that changed compared to Emumyc+mTR+/+ tumors. Emumyc+mTR-/-G6 tumors showed a 52-fold increase compared to Emumyc+mTR+/+ tumors. These findings suggest that telomerase deficient tumor cells with short telomeres are likely increased for telomere recombination. We then compared the number of pq-ratio changes in tumors and primary cells and found that tumors from both early Emumyc+mTR-/- G1 and late Emumyc+mTR-/- G4/G6 generation mice were increased in the amount of pq-ratio changes compared to the primary bone marrow from the same generation (Figure 2H). Emumyc+ mTR+/+ tumors were also slightly increased for changes in the pq-ratios compared to Emumyc+mTR+/+ primary cells, perhaps due to selection for increased recombination during growth of the tumor. Similar observations were made between the primary splenocytes and tumors. Our data indicate that telomerase negative tumor cells have an elevated amount of telomere recombination compared to primary cells. Furthermore, it illustrates that some non-telomerase telomere maintenance mechanisms have a minimal effect on the average telomere length.
###end p 33
###begin title 34
Outliers Are Increased in Primary and Tumor Cells with Short Telomeres
###end title 34
###begin p 35
###xml 379 388 379 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g003">Figure 3A</xref>
While the pq-ratio assay is very sensitive, the data may become biased as the telomeres shorten. Small changes on a short telomere may be over-represented and telomeres with no signal will not be represented at all. Thus we used a second statistical test to assay for length changes. We determined the distribution of the telomere lengths and quantitated the number of outliers (Figure 3A), which are telomere lengths more than two standard deviations from the median. These outliers numerically represent exceptionally long and short telomeres in the distribution.
###end p 35
###begin title 36
Late generation mTR-/- primary cells have a significantly greater number of telomere outliers.
###end title 36
###begin p 37
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
Data acquired from Q-FISH were used to generate box plots. The darkened line within the box represents the 50th percentile, the median telomere length of the distribution. The box includes telomere length values and is approximately one standard deviation. The lines extending from outside the box represent approximately two standard deviations (95th and 5th percentile). Telomere lengths outside of these are outliers and appear as dots. Since some data points overlap, the total amount of outliers is graphically quantitated in B, and is normalized for the total number of metaphases examined. B. The graph shows the total number of outliers divided by the total number of metaphases (n) for each genotype plotted on the left y-axis. Error bars represent the standard error of the mean (SEM). Circles reflect the mean telomere length plotted on the right y-axis. Calculated p-values (alpha = .05) using the Wilcoxon rank sum test indicate a statistically significant difference between mTR+/+ and mTR-/-G4 bone marrow (P = .004). Similarly mTR-/-G4 splenocytes have a statistically greater number of outliers in comparison to mTR+/+ splenocytes (P = .008).
###end p 37
###begin p 38
###xml 137 146 137 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g003">Figure 3A</xref>
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g003">Figure 3B</xref>
The telomere length distribution acquired from Q-FISH for each genotype was determined and examined to identify outliers (shown as dots, Figure 3A). We found mTR-/-G4 bone marrow and splenocytes cells had a significantly greater number of outliers per metaphase compared to mTR+/+ cells (Figure 3B). This result is consistent with the findings observed with the pq-ratio analysis, and suggests that short telomeres may initiate telomere recombination.
###end p 38
###begin title 39
Emumyc+mTR-/- Tumors Are Increased for Subtelomeric Recombination
###end title 39
###begin p 40
###xml 676 685 676 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g004">Figure 4A</xref>
###xml 1067 1082 1067 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g004">Figure 4B and C</xref>
###xml 1308 1317 1306 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g004">Figure 4D</xref>
###xml 2081 2090 2078 2087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g004">Figure 4E</xref>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
###xml 796 801 <span type="species:ncbi:4932">yeast</span>
Our data suggest that abrupt changes in telomere length occur on short telomeres. To directly test whether recombination is occurring in these cells, we developed a subtelomeric recombination assay. We examined the mouse genome sequence for unique loci contained in subtelomeric regions, and identified a terminal BAC clone located at H4 on mouse chromosome 2, which also contained subtelomeric sequences directly adjacent to telomere repeats in the genome. We initially hybridized this sequence to mTR+/+ cells to confirm the copy number of this subtelomeric BAC clone and found the clone hybridized to only two chromosomal termini in wildtype bone marrow metaphase spreads (Figure 4A). We reasoned that if recombination in the telomeric region occurs in the subtelomeric regions, as it does in yeast, amplification and transfer of this sequence to the telomeres of other chromosomes would occur. To determine the frequency of this sequence amplification and transfer, we hybridized metaphase spreads with both the BAC clone and a chromosome 2 specific paint probe (Figure 4B and C). We first examined the Emumyc+mTR-/- G5 lymphomas. Consistent with subtelomeric recombination, we observed 51% of the metaphases had amplified this subtelomeric region in the Emumyc+mTR-/- G5 lymphomas with short telomeres (Figure 4D). We observed no metaphases with amplified subtelomeric sequence in primary mTR+/+ bone marrow. In the Emumyc+mTR+/+ lymphomas there was a low level of amplification of this sequence likely due to increased recombination in the tumors (10%). In addition we observe the amount of subtelomeric recombination in mTR-/- MEFs, when restored for mTR have a reduced number of changes in both pq-ratios and the frequency of subtelomeric recombination (unpublished data). Given that early passage primary cells lack fusions, its unlikely that bridge fusion breakage cycles contribute to the amplification of the sequence. This subtelomeric amplification and transfer of a unique locus to additional chromosomes correlated directly with increased changes in the pq-ratios (Figure 4E), suggesting that BIR could account for both processes.
###end p 40
###begin title 41
Subtelomeric recombination is frequent in Emumyc+mTR-/-G5 tumors.
###end title 41
###begin p 42
###xml 890 892 885 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1189 1191 1180 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Multicolor FISH using a BAC that maps to the subtelomeric region (green) of mouse chromosome 2 hybridized to metaphase spreads. Chromosome 2 was hybridized with a chromosome specific probe (red). Chromosomes with subtelomeric amplification are indicated with a white arrow. A. mTR+/+ bone marrow. B-C. Emumyc+mTR-/-G5 tumors have amplified this subtelomeric sequence to other chromosomes, white arrows. D. Percent of metaphases with subtelomeric amplification (left, y-axis) and the mean telomere length (right, y-axis). Error bars represent the standard deviation. Subtelomeric amplification is increased in cells with short telomeres, and also appears at reduced levels in myc+mTR+/+ lymphomas. Fifty metaphases were scored for each genotype. Student T-tests, assuming alpha = .05, show statistical significance difference between the myc+mTR+/+ and the myc+mTR-/-G5 lymphomas (P = 5.0x10-5). E. Cells with an increased number of pq-ratio changes are also elevated for subtelomeric amplification. Error bars represent the standard deviation. Student T-tests, assuming alpha = .05, show statistical significance difference between the myc+mTR+/+ and the myc+mTR-/-G5 lymphomas (P = 6.8x10-6).
###end p 42
###begin title 43
Short Telomeres in mTR-/- Primary Cells from an Intergenerational Cross Show Increased Recombination
###end title 43
###begin p 44
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hemann2">[25]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser2">[26]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hemann2">[25]</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
To more specifically examine whether short telomeres are substrates for recombination, we used mice from an intergenerational cross [25],[26]. All progeny from this type of cross inherit chromosomes with 50% short and 50% long telomeres. Previous studies showed that when late generation mTR-/- mice were crossed with mTR+/- mice, the shortest telomeres were specifically elongated in mTR+/- mice [25].
###end p 44
###begin p 45
###xml 89 98 89 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g005">Figure 5A</xref>
###xml 326 342 326 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g005">Figure 5B, arrow</xref>
###xml 487 496 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g005">Figure 5C</xref>
###xml 698 707 698 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g005">Figure 5D</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
For our analysis, we crossed late generation telomerase mTR-/- G5 mice with mTR+/- mice (Figure 5A). Bone marrow was harvested from mTR-/- iG6 and mTR+/- iG6 mice and analyzed by Q-FISH. We observed that the shortest telomeres from mTR+/- iG6 mice were extended, while critically short telomeres persisted in mTR-/- iG6 mice (Figure 5B, arrow). When we examined the pq-ratios, we found a significant increase in the pq-ratios that changed in mTR-/- iG6 mice compared to mTR+/- iG6 mice (Figure 5C). Outlier analysis of telomere lengths from this intergenerational cross also indicated a significantly greater number of outliers per metaphase in the mTR-/- iG6 mice compared to the mTR+/- iG6 mice (Figure 5D). These data strongly suggest that short telomeres are substrates for recombination. We also noted that the mTR+/- iG6 mice displayed a small amount of pq-ratio changes and had some outliers. This small, yet detectable amount of pq-ratio changes and outliers in the mTR+/- intergenerational mice suggested that perhaps telomere recombination occurs in the presence of telomerase.
###end p 45
###begin title 46
iG6 mTR-/- cells from an intergenerational cross have an increase in pq-ratio changes and outliers.
###end title 46
###begin p 47
###xml 573 576 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
A. The breeding scheme used to generate intergenerational (iG6) mice results in progeny with half short and half long telomeres. B. Q-FISH on primary bone marrow cells isolated from mTR-/- iG6 and mTR+/-iG6 mice. The arrow points to the class of shortest telomeres that persist in the iG6 mTR-/- mice. C. Summary of pq-ratio analysis on bone marrow cells. Circles represent the mean telomere length. Using a T-test (alpha = .05) statistical significance was observed between the number of ratios with q/p>/=5-fold for mTR-/- iG6 and mTR+/- iG6 bone marrow cells (P = 2.2x10-15). D. Box plot analysis used to determine the number of telomere "outliers" is plotted on the left y-axis. Circles represent the mean telomere length and are plotted on the right y-axis. Using a Wilcoxon rank sum test (alpha = .05), mTR-/- iG6 bone marrow cells have a statistically greater number of outliers compared to mTR+/- iG6 (P = .003).
###end p 47
###begin title 48
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
Short Telomeres Initiate Recombination in CAST/EiJ Mice, Even in the Presence of Telomerase
###end title 48
###begin p 49
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hao1">[10]</xref>
###xml 458 462 458 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 526 530 526 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 537 552 537 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g006">Figure 6A and B</xref>
###xml 714 723 714 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g006">Figure 6C</xref>
###xml 728 741 728 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s004">Figure S4 A&#8211;C</xref>
###xml 743 746 743 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Hemann1">[9]</xref>
###xml 1099 1103 1099 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 1110 1114 1110 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 1190 1199 1190 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g006">Figure 6D</xref>
###xml 1204 1214 1204 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s004">Figure S4D</xref>
###xml 1481 1490 1481 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g006">Figure 6E</xref>
###xml 1495 1505 1495 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s004">Figure S4E</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
###xml 1115 1119 <span type="species:ncbi:10090">mice</span>
###xml 1184 1188 <span type="species:ncbi:10090">mice</span>
To test more directly whether some short telomeres may recombine in the presence of telomerase, we utilized mTR+/- CAST/EiJ mice. As described previously, telomere shortening occurs in late generation mTR+/+ and mTR+/- (termed WT#* and HG#) CAST/EiJ mice [10]. We assayed littermates from both early and late generation heterozygous intercrosses, including a cross from the first generation of heterozygous mice (HG1) which yielded WT2*, HG2, and knockout KO(G2) mice and a cross of HG5 parents which yielded WT6*, HG6, and KO(G6) mice (Figure 6A and B). Since telomeres are shorter and more homogenous in the CAST/EiJ strain compared to C57BL/6J, we examined telomere length by both Southern blotting and Q-FISH (Figure 6C and Figure S4 A-C) [9]. We observed that the WT* mice from the late generation HG5 intercross (WT6*), had shorter telomeres than true wildtype (WT) and early generation WT2* mice. We also observed that the telomeres from the late generation HG6 mice were shorter than HG2 mice. We next examined the pq-ratio changes and the number of telomere outliers. WT6*, HG6, and both KO(G2) and KO(G6) mice, had a significant increase in changed pq-ratios compared to WT mice (Figure 6D and Figure S4D). These findings illustrate pq-ratios changes increase in cells with short telomeres, even in the presence of telomerase. Consistent with this finding, we also observed an increase in the amount of outliers in bone marrow and splenocytes cells with short telomeres (Figure 6E and Figure S4E). Together the pq-ratio and outlier analysis suggest that short telomeres may initiate recombination even when telomerase is present at wildtype levels as in the WT6*.
###end p 49
###begin title 50
Short CAST/EiJ telomeres even in the presence of telomerase show increased pq-ratio changes.
###end title 50
###begin p 51
###xml 731 735 725 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 747 749 741 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 758 762 752 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 774 777 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 1086 1090 1076 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 1108 1112 1098 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
A and B. Q-FISH on primary bone marrow isolated from early generation (HG1xHG1) and late generation (HG5xHG5) CAST/EiJ mice. The breeding scheme used to generate the CAST/EiJ mice is shown above the Q-FISH plots. C. Southern analysis on bone marrow cells isolated from the same mice shown in A and B. D. The pq-ratios of primary bone marrow cells are plotted as described above. The percent of the total number of chromosomes with telomere ratio values q/p>/=5-fold is plotted on the left y-axis. The circles represent the mean telomere lengths of each genotype plotted on the right y-axis. A T-test (alpha = .05) was used to determine statistical significance between WT bone marrow cells versus WT6* (P = .04), HG6 (P = .002), KO(G2) (P = 8.8x10-5), and KO(G6) (P = 5.9x10-11). E. Summary of outliers generated from box plots. The outliers per metaphase are plotted on the left y-axis. The circles represent the mean telomere length plotted on the right y-axis. A Wilcoxon rank sum test (alpha = .05) was used to calculate statistical significance between WT versus HG2 (P = .009), KO(G2) (P = .016) and KO(G6) (P = .0001).
###end p 51
###begin title 52
Telomere Sister Chromatid Exchanges Are Detected in Only a Subset of Primary Cells with Short Telomeres
###end title 52
###begin p 53
###xml 342 346 342 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 390 398 390 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g007">Figure 7</xref>
###xml 511 520 511 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g007">Figure 7E</xref>
###xml 601 605 601 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 1089 1093 1089 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 1312 1316 1312 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
Since T-SCE has been documented in ALT cells, we wanted to determine whether this type of recombination could account for the pq-ratio changes occurring in primary cells. Using the CO-FISH assay we examined littermates from late generation (HG5xHG5) CAST/EiJ mice and WT CAST/EiJ mice for T-SCE. Primary bone marrow from WT, WT6*, HG6, and KO(G6) mice was isolated and examined by CO-FISH (Figure 7). In WT6* and HG6 mice with short telomeres, we observed only a small amount of T-SCEs (0.05 T-SCEs/chromosome, Figure 7E). Similar frequencies were observed in bone marrow from wildtype mice. In the KO(G6) bone marrow cells the amount of T-SCEs was significantly higher (0.25 T-SCEs/chromosome) when compared to WT6* and HG6. However, in splenocytes we observed a similar frequency of T-SCEs for all genotypes (0.04-0.07 T-SCEs/chromosome). The dissimilar amount of T-SCEs between cell types could be due differences in the type of recombination mechanism contributing to the telomere maintenance in splenocytes versus bone marrow. The difference in the number of T-SCEs in the WT6* and KO(G6) bone marrow is unlikely due to differences in replication rate of these cells, since both genotypes have similar proliferation rates (Morrish, Armanios and Alder, unpublished data). Instead the increase in T-SCEs in KO(G6) bone marrow cells compared to WT6* implies that T-SCEs may be one type of recombination mechanism that occurs with short telomeres.
###end p 53
###begin title 54
CO-FISH detects frequent exchanges in only some primary mTR-/- cells.
###end title 54
###begin p 55
###xml 539 543 539 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 752 756 748 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
A. A diagram of CO-FISH analysis. In the CO-FISH assay, cells are grown in the presence of 5-bromo-2-deoxyuridine (BrdU). After one round of replication one strand (green) has incorporated BrdU. Metaphases are treated with Hoechst and UV treated, which nicks the BrdU incorporated strand. The nicked strands are then degraded with an exonuclease, followed by hybridization with a telomere probe. B-D. CO-FISH on primary bone marrow cells isolated from the progeny of late generation (HG5xHG5) CAST/EiJ mice WT6* (n = 3), HG6 (n = 3) and KO(G6) (n = 3). WT (n = 3) mice were also examined. E. Summary of T-SCEs in primary CAST/EiJ bone marrow cells. A T-test (alpha = .05) was used and showed a significant increase in the amount of T-SCEs in primary KO(G6) bone marrow (P = .003) compared to WT bone marrow.
###end p 55
###begin title 56
###xml 19 24 <span type="species:ncbi:9606">Human</span>
Short Telomeres in Human Cells Show Evidence of Increased Recombination
###end title 56
###begin p 57
###xml 345 356 345 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g008">Figure 8A&#8211;C</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Armanios1">[27]</xref>
###xml 512 521 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g008">Figure 8D</xref>
###xml 724 733 724 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g008">Figure 8E</xref>
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
###xml 951 956 <span type="species:ncbi:9606">human</span>
While human ALT tumor cells show greatly elongated telomeres, we wondered if primary human cells with short telomeres might utilize telomere recombination, without telomere lengthening. We thus examined both pq-ratios and outliers in lymphocyte cells from dyskeratosis congenita patients with short telomeres due to a mutation in hTERT (K902N) (Figure 8A-C) [27]. Individuals with short telomeres had a significantly greater amount of changes in pq-ratios in comparison to non-carriers (hTERT+/+) in the family (Figure 8D). Analysis of the frequency of outliers per metaphase also demonstrated that carriers with short telomeres had a significantly greater number of outliers compared to non-carriers with longer telomeres (Figure 8E). Thus, short telomeres in human primary cells show evidence of increased telomere recombination, even in the presence of limiting telomerase. This data suggests that some telomere maintenance mechanisms may occur in human cells without a substantial increase in the telomere length distribution.
###end p 57
###begin title 58
Lymphocytes from hTERT+/- individuals are increased for pq-ratio changes and outliers.
###end title 58
###begin p 59
A and B. Shown are the Q-FISH results on lymphocytes from various individuals in a family harboring a mutation in hTERT (hTERT+/K902N) or from non-carriers hTERT+/+. C. Summary of Q-FISH analysis from related individuals with hTERT+/K902N (n = 4) and hTERT+/+ (n = 6) genotypes. D. The total number of chromosomes with telomere ratio values q/p>/=5-fold is plotted on the left y-axis. The black circle denotes the mean telomere length plotted on the right y-axis. Using a T-test (alpha = .05), comparison of hTERT+/+ with hTERT+/K902N shows a significant difference (P = .02). E. The total number of outliers per metaphase is plotted on the left y-axis. Black circles represent the mean telomere length plotted on the right y-axis. Using a Wilcoxon rank sum test (alpha = .05) a significantly greater number of outliers were observed in hTERT+/K902N in comparison to hTERT+/+ (P = .034).
###end p 59
###begin title 60
Discussion
###end title 60
###begin title 61
Short Telomeres Initiate Recombination in Primary Mammalian Cells
###end title 61
###begin p 62
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-McEachern2">[24]</xref>
###xml 160 165 <span type="species:ncbi:4932">yeast</span>
###xml 925 930 <span type="species:ncbi:4932">yeast</span>
Telomere lengthening is predominantly carried out by telomerase, however other mechanisms including recombination can contribute to telomere length changes. In yeast, short telomeres can stimulate telomere recombination, perhaps due to the loss of telomere capping [24]. Consistent with recombination occurring at short telomeres in mammalian cells, we found an increase in pq-ratio changes and outliers in both telomerase negative and positive cells. Late generation mTR-/- cells with the shortest telomeres showed the greatest amount of pq-ratio changes, and outliers in primary bone marrow and splenocytes. Furthermore, late generation mTR-/- tumor cells were elevated for these changes compared to primary cells. This increase in telomere length fluctuation likely occurs by a recombination-based mechanism, as we found an increased rate of subtelomeric sequence amplification in cells with short telomeres. Thus like in yeast cells, telomeric and subtelomeric recombination is elevated at short, possibly dysfunctional telomeres.
###end p 62
###begin p 63
###xml 170 175 <span type="species:ncbi:9606">human</span>
The increase in telomeric recombination occurred even in cells having functional telomerase alleles. Primary cells with short telomeres from CAST/EiJ WT*, mTR+/-, and in human samples with mutations in hTERT showed increased telomere length changes, supporting the idea that telomere recombination mechanisms can occur in the presence of telomerase. Additionally the increase in subtelomeric recombination in late passage mTR+/+ MEFs further demonstrates that both telomerase and recombination can maintain short telomeres. This increased telomere recombination at short telomeres in the presence of telomerase suggest that the telomerase enzyme does not directly contribute to end protection. Thus, the initiation of telomere recombination is more likely due to the disruption of the capping structure at short telomeres, and not the loss of telomerase.
###end p 63
###begin title 64
Multiple Mechanisms Alter Telomere Ratios
###end title 64
###begin p 65
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Teng1">[20]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Le1">[22]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-McEachern1">[23]</xref>
###xml 24 29 <span type="species:ncbi:4932">yeast</span>
###xml 630 635 <span type="species:ncbi:4932">yeast</span>
###xml 1150 1155 <span type="species:ncbi:10090">mouse</span>
Studies of survivors in yeast indicate that telomere recombination can occur by multiple mechanisms. Specifically, two different survivor pathways have been described for telomere recombination. Type I survivors have short telomere tracts and BIR occurs in subtelomeric sequences called Y' elements. Type II survivors have long telomere tracts and BIR occurs within the telomere repeats themselves [20],[22]. Our findings suggest that mammalian cells also can use various types of recombination mechanisms for telomere maintenance, and that ALT does not occur by a single mechanism. BIR is considered the predominant mechanism in yeast for telomere elongation in survivors [23]. We identified an increased number of metaphases in telomerase deficient lymphomas with subtelomeric recombination, indicative of additional recombination based mechanisms. For instance, degradation of short telomeres into subtelomeric regions likely exposes various types of repetitive sequences. When sequence homology with another chromosome is encountered, strand invasion and copying of the terminal region occurs. The transfer of this unique subtelomeric locus from mouse chromosome 2 to different chromosomes is consistent the possibility of a BIR-like mechanism.
###end p 65
###begin p 66
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Benetti1">[33]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Wang1">[34]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Wang2">[35]</xref>
###xml 737 762 737 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Miller1">[36]</xref>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Karlseder1">[37]</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 737 762 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
While T-SCEs are typically used as the main measure of telomere recombination in human ALT cells, it is important to note that BIR pathways would not be detected by the CO-FISH method. Although we did detect T-SCE in the bone marrow cells, the number of T-SCEs did not explain the frequency of telomere length variations, indicating others mechanisms must also play a role [33],[34]. In addition, CO-FISH is limited when telomeres are very short, since T-SCEs at short telomeres are very difficult to detect due to the resolution of the telomere probe [35]. In addition, some of the accumulating changes in pq-ratios may also arise as a consequence of stalled replication forks that might be accompanied with dysfunctional telomeres. In Schizosaccharomyces pombe, deletion of Taz1, the ortholog of the telomere binding proteins TRF1 and TRF2, can result in replication fork stalling [36],[37]. These studies suggest that dysfunctional telomeres due to the immediate loss of telomere end binding proteins in mammalian cells may result in replication fork stalling, however such intermediates would be predicted to invoke recombination. Thus using pq-ratio and outlier analysis allows detection of various types of recombination.
###end p 66
###begin title 67
###xml 54 59 <span type="species:ncbi:10090">Mouse</span>
Non-Telomerase Mechanisms for Telomere Maintenance in Mouse Cells Have a Minimal Effect on Overall Telomere Length
###end title 67
###begin p 68
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Bryan3">[38]</xref>
###xml 335 338 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Feldser1">[7]</xref>
###xml 1140 1144 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000357-Chen1">[21]</xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 270 285 <span type="species:ncbi:10090">transgenic mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 930 935 <span type="species:ncbi:4932">yeast</span>
###xml 1486 1491 <span type="species:ncbi:9606">human</span>
###xml 1521 1526 <span type="species:ncbi:10090">mouse</span>
###xml 1640 1645 <span type="species:ncbi:4932">yeast</span>
###xml 1675 1680 <span type="species:ncbi:9606">human</span>
###xml 1763 1768 <span type="species:ncbi:9606">human</span>
###xml 1779 1784 <span type="species:ncbi:10090">mouse</span>
The use of ALT for telomere maintenance in human cells has characteristically been associated with a dramatic lengthening of telomeres [38]. In contrast, we find in many instances telomere maintenance can occur without extensive telomere elongation. In Emumyc+mTR-/- G6 transgenic mice, short telomeres dramatically limit tumor growth [7]. However, in a few mice, tumors somehow overcome the short telomeres and continue to grow. When these Emumyc+mTR-/- tumors were transferred serially through several mice the telomere length was not significantly changed indicating that these tumor cells must utilize non-telomerase mechanisms for telomere length maintenance. However, in sharp contrast to many ALT cell lines, telomeres from these mTR-/- cells did not exhibit a dramatic telomere lengthening. This result of telomere maintenance without significant telomere elongation is very similar to what is seen in Type I survivors in yeast. In Type I survivors the telomeres are very short and yet they are maintained following many doublings and exemplify that not all telomere recombination mechanisms result in dramatic telomere lengthening [21]. In contrast the telomere repeat tracts in Type II survivors are dramatically longer than in wildtype cells. Both Type I and Type II survivors can be generated in a population of cells. Yet due to the growth advantage of Type II survivors in liquid culture, only Type II survivors are seen following extensive growth. The difference between human ALT tumor cell lines and the mouse tumor cells shown here suggests that there may be multiple pathways for recombination in mammals as there are in yeast. One type may predominate in human ALT tumors and immortalized cells and another type may be more favored in primary human cells and mouse cells. Future studies will provide insight into the mechanism of the different pathways and their requirement for the growth of tumors in the absence of telomerase.
###end p 68
###begin title 69
Supporting Information
###end title 69
###begin p 70
###xml 571 580 571 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g002">Figures 2</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g003">3</xref>
###xml 591 600 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000357.s003">Figure S3</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
Q-FISH analysis on various mTR-/- cells. A. Histogram plots of Q-FISH analysis on B-cell lymphomas. B. Histogram plots of Q-FISH on primary bone marrow from myc+mTR+/+ and early and late generation myc+ mTR-/- mice. C. Histogram plots of Q-FISH on primary splenocytes from the same mice as in B. D. Q-FISH on primary bone marrow show that the telomeres of late generation mTR-/-G4 cells are shorter than WT and early generation mTR-/-G1 cells, WT (n = 3), mTR-/-G1 (n = 3), mTR-/-G4 (n = 2). E. Splenocytes from the same mice as in D. This FISH data was used to generate Figures 2 and 3 and Figure S3.
###end p 70
###begin p 71
(1.70 MB TIF)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Pq-ratios determined for mouse chromosome 1. A. Shown are the results of a metaphase spread hybridized with mouse chromosome 1 paint probe (green) and a Cy3-labled telomere PNA probe (red). B. The pq-ratios for a myc+mTR+/+ lymphoma are plotted on a log-scale and were typically near 1. C. The pq-ratios for chromosome 1 from a myc+mTR-/-G5 lymphoma are variable with some ratios near 10- and 100-fold.
###end p 73
###begin p 74
(5.04 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
Pq-ratios on every chromosome for B-cell lymphomas. The pq-ratio plots of every chromosome from multiple metaphases and similar to analysis for mouse chromosome 1 show a dramatic increase in pq-ratio changes in myc+mTR-/-G1 and myc+mTR-/-G6 lymphomas compared to myc+mTR+/+ lymphomas. A and B. Metaphase spreads and pq-ratio plots from myc+mTR+/+ lymphoma hybridized with telomere probe. C and D. Metaphase spreads and pq-ratio plots from myc+mTR-/-G1 lymphoma hybridized with telomere probe. E and F. Metaphase spreads and pq-ratio plots from myc+mTR-/-G6 lymphoma hybridized with telomere probe.
###end p 76
###begin p 77
(7.73 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000357-g006">Figure 6</xref>
###xml 248 252 248 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 331 335 331 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 771 775 759 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 785 787 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 799 803 787 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 815 818 803 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;13</sup>
###xml 885 889 871 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G2)</sub>
###xml 896 900 882 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 1184 1188 1166 1170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6)</sub>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
CAST/EiJ mTR-/- splenocytes are increased in pq-ratio changes and outliers. Shown is the telomere length analysis of splenocytes from the mice described in Figure 6. A. Histogram plots of Q-FISH from the progeny of a HG1xHG1 cross: WT2*, HG2 and KO(G2). B. Histogram plots of Q-FISH from progeny of a HG5xHG5 cross WT6*, HG6 and KO(G6). C. Southern analysis on samples from CAST/EiJ splenocytes of the genotypes shown in A and B. D. The percent of chromosomes with a telomere ratio value q/p>/=5-fold is plotted on the left y-axis. T-tests (alpha = .05) on pq-ratio analysis of splenocytes shows a statistically greater amount of telomeres with ratio values of q/p>/=5-fold in HG6 cells in comparison to WT (P = .007). T-tests (alpha = .05) comparing WT cells with mTR-/-(G2) (P = 4x10-9) and mTR-/-(G6) (P = 1.4x10-13) show a significantly greater amount of q/p ratios>/=5-fold for KO(G2) and KO(G6) Black circles represent the mean telomere length plotted on the right y-axis. Error bars represent the SEM. E. The total number of outliers per metaphase is plotted on the left y-axis. A Wilcoxon rank sum test was used to test statistical significance (alpha = .05) between WT and KO(G6), however no statistical significance was observed (P = 0.9). Black circles represent the mean telomere lengths plotted on the right y-axis. Error bars represent the SEM.
###end p 79
###begin p 80
(5.74 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:10090">mouse</span>
We are grateful for the statistical advice from Carol Thompson in the Bloomberg School of Public Health. We also appreciate the metaphases from human lymphocytes provided by Dr. Mary Armanios. In addition we thank Margaret Strong for excellent assistance with the mouse colony and breeding and Amy Sexauer for helping with the initial stages of the serial MEF passages. We also thank Dr. Jef Boeke and members of the Greider and Armanios laboratories for critical comments on the manuscript and helpful discussions during the course of the work.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.
###end article-title 84
###begin article-title 85
###xml 23 28 <span type="species:ncbi:9606">human</span>
Telomerase activity in human germline and embryonic tissues and cells.
###end article-title 85
###begin article-title 86
Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation.
###end article-title 86
###begin article-title 87
###xml 73 78 <span type="species:ncbi:9606">human</span>
Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.
###end article-title 87
###begin article-title 88
###xml 24 29 <span type="species:ncbi:9606">human</span>
Specific association of human telomerase activity with immortal cells and cancer.
###end article-title 88
###begin article-title 89
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.
###end article-title 89
###begin article-title 90
Short telomeres limit tumor progression in vivo by inducing senescence.
###end article-title 90
###begin article-title 91
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Hypervariable ultra-long telomeres in mice.
###end article-title 91
###begin article-title 92
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Wild-derived inbred mouse strains have short telomeres.
###end article-title 92
###begin article-title 93
Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
###end article-title 93
###begin article-title 94
###xml 57 62 <span type="species:ncbi:9606">human</span>
Telomere length dynamics in telomerase-positive immortal human cell populations.
###end article-title 94
###begin article-title 95
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
###end article-title 95
###begin article-title 96
###xml 33 38 <span type="species:ncbi:9606">human</span>
Telomere dynamics in an immortal human cell line.
###end article-title 96
###begin article-title 97
###xml 41 46 <span type="species:ncbi:9606">human</span>
Telomere maintenance by recombination in human cells.
###end article-title 97
###begin article-title 98
###xml 33 38 <span type="species:ncbi:9606">human</span>
Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
###end article-title 98
###begin article-title 99
Telomere uncapping and alternative lengthening of telomeres.
###end article-title 99
###begin article-title 100
Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.
###end article-title 100
###begin article-title 101
Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
###end article-title 101
###begin article-title 102
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
An alternative pathway for yeast telomere maintenance rescues est1- senescence.
###end article-title 102
###begin article-title 103
###xml 91 115 91 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 91 115 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae.
###end article-title 103
###begin article-title 104
Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events.
###end article-title 104
###begin article-title 105
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD51 and RAD50</italic>
RAD51 and RAD50 define two pathways that collaborate to maintain telomeres in the absence of telomerase.
###end article-title 105
###begin article-title 106
###xml 69 74 <span type="species:ncbi:4932">yeast</span>
Break-induced replication and recombinational telomere elongation in yeast.
###end article-title 106
###begin article-title 107
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
Short telomeres in yeast are highly recombinogenic.
###end article-title 107
###begin article-title 108
The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.
###end article-title 108
###begin article-title 109
Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres.
###end article-title 109
###begin article-title 110
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.
###end article-title 110
###begin article-title 111
Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway.
###end article-title 111
###begin article-title 112
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats.
###end article-title 112
###begin article-title 113
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.
###end article-title 113
###begin article-title 114
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
###end article-title 114
###begin article-title 115
Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres.
###end article-title 115
###begin article-title 116
###xml 53 59 <span type="species:ncbi:10090">murine</span>
An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.
###end article-title 116
###begin article-title 117
###xml 59 65 <span type="species:ncbi:10090">murine</span>
Telomere sister chromatid exchange in telomerase deficient murine cells.
###end article-title 117
###begin article-title 118
Semi-conservative DNA replication through telomeres requires Taz1.
###end article-title 118
###begin article-title 119
Telomeric proteins: clearing the way for the replication fork.
###end article-title 119
###begin article-title 120
###xml 32 37 <span type="species:ncbi:9606">human</span>
Telomere elongation in immortal human cells without detectable telomerase activity.
###end article-title 120
###begin p 121
The authors have declared that no competing interests exist.
###end p 121
###begin p 122
This work was funded by grants from the NIH, PO1 CA16519, and from the Leukemia and Lymphoma Society, 5048-07. TAM is currently a Leukemia and Lymphoma Society Fellow.
###end p 122

